Stelli (603520.SH) announced that the company received it from the China Securities Regulatory Commission on March 13, 2024...
Zhitong Financial App News, Sitaili (603520.SH) announced that on March 13, 2024, the company received the “Approval Notice Concerning the Registration of Zhejiang Sitaili Pharmaceutical Co., Ltd. to issue shares to specific targets” issued by the China Securities Regulatory Commission (hereinafter referred to as the “China Securities Regulatory Commission”). The China Securities Regulatory Commission approved the company's registration application to issue shares to specific targets.